Intellipharmaceutics International Inc. (OTCMKTS:IPCIF – Get Free Report) (TSE:I) shares crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.06 and traded as high as $0.10. Intellipharmaceutics International shares last traded at $0.10, with a volume of 2,065 shares traded.
Intellipharmaceutics International Stock Performance
The stock has a market capitalization of $3.31 million, a P/E ratio of -0.63 and a beta of 1.16. The stock has a 50 day moving average of $0.06 and a 200 day moving average of $0.06.
Intellipharmaceutics International Company Profile
Intellipharmaceutics International Inc, a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in various therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain.
Featured Stories
- Five stocks we like better than Intellipharmaceutics International
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- Using the MarketBeat Stock Split Calculator
- Generac Powers Ahead on the Electrification Mega-Trend
- Retail Stocks Investing, Explained
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Intellipharmaceutics International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intellipharmaceutics International and related companies with MarketBeat.com's FREE daily email newsletter.